Potentiation of human papilloma vaccine candidate using naloxone/alum mixture as an adjuvant: increasing immunogenicity of HPV-16E7d vaccine
Objective(s): Many types of human papillomaviruses (HPVs) have been identified, with some leading to cancer and others to skin lesions such as anogenital warts. Studies have demonstrated an association between oncogenic HPV and cervical cancer and many researchers have focused on therapeutic vaccine...
محفوظ في:
| المؤلفون الرئيسيون: | , |
|---|---|
| التنسيق: | Artigo |
| اللغة: | Inglês |
| منشور في: |
Mashhad University of Medical Sciences
2016-09-01
|
| سلاسل: | Iranian Journal of Basic Medical Sciences |
| الموضوعات: | |
| الوصول للمادة أونلاين: | http://ijbms.mums.ac.ir/article_7601_7e0174fa36c71839d11391fe471bb02d.pdf |
| الوسوم: |
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
|